Rhinitis, Allergic, Perennial and Seasonal Clinical Trial
Official title:
Pharmacokinetic Study of Levocetirizine Oral Solution-An Open-label, Randomized, Cross-over Study to Evaluate the Pharmacokinetics, the Safety and Tolerability of Levocetirizine Oral Solution (5 mg) and Cetirizine Dry Syrup (10 mg), Following a Single Dose in Japanese Healthy Male Subjects-
This study will be a single center, open-label, randomized, single dose, in the fasted
condition and 2-way crossover study to evaluate the pharmacokinetics, the safety and
tolerability of levocetirizine oral solution 5 mg and cetirizine dry syrup 10 mg in Japanese
healthy male subjects.
Approximately 20 subjects will receive both treatments of levocetirizine oral solution 5 mg
and cetirizine dry syrup 10 mg in the design. Serial pharmacokinetic samples will be
collected and safety assessments will be performed following each dose.
The primary objective of the study is to demonstrate the bioequivalence of levocetirizine in
plasma, when given as levocetirizine oral solution 5 mg relative to cetirizine DS 10 mg in
Japanese healthy male subjects.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02424539 -
A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
|
Phase 4 | |
| Completed |
NCT01949051 -
A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
|
Phase 2 | |
| Completed |
NCT01957202 -
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
|
Phase 2 | |
| Completed |
NCT01962467 -
A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
|
Phase 1 | |
| Completed |
NCT01001130 -
Regulatory AVAMYS Nasal Spray PMS
|
N/A | |
| Completed |
NCT02397915 -
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
|
Phase 4 | |
| Completed |
NCT01445262 -
Drug Use Investigation for XYZAL®
|
N/A | |
| Completed |
NCT01916226 -
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
|
Phase 4 | |
| Completed |
NCT00109486 -
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
|
Phase 3 |